Artificial intelligence performance in ultrasound-based lymph node diagnosis: a systematic review and meta-analysis.

IF 3.4 2区 医学 Q2 ONCOLOGY BMC Cancer Pub Date : 2025-01-13 DOI:10.1186/s12885-025-13447-y
Xinyang Han, Jingguo Qu, Man-Lik Chui, Simon Takadiyi Gunda, Ziman Chen, Jing Qin, Ann Dorothy King, Winnie Chiu-Wing Chu, Jing Cai, Michael Tin-Cheung Ying
{"title":"Artificial intelligence performance in ultrasound-based lymph node diagnosis: a systematic review and meta-analysis.","authors":"Xinyang Han, Jingguo Qu, Man-Lik Chui, Simon Takadiyi Gunda, Ziman Chen, Jing Qin, Ann Dorothy King, Winnie Chiu-Wing Chu, Jing Cai, Michael Tin-Cheung Ying","doi":"10.1186/s12885-025-13447-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Accurate classification of lymphadenopathy is essential for determining the pathological nature of lymph nodes (LNs), which plays a crucial role in treatment selection. The biopsy method is invasive and carries the risk of sampling failure, while the utilization of non-invasive approaches such as ultrasound can minimize the probability of iatrogenic injury and infection. With the advancement of artificial intelligence (AI) and machine learning, the diagnostic efficiency of LNs is further enhanced. This study evaluates the performance of ultrasound-based AI applications in the classification of benign and malignant LNs.</p><p><strong>Methods: </strong>The literature research was conducted using the PubMed, EMBASE, and Cochrane Library databases as of June 2024. The quality of the included studies was evaluated using the QUADAS-2 tool. The pooled sensitivity, specificity, and diagnostic odds ratio (DOR) were calculated to assess the diagnostic efficacy of ultrasound-based AI in classifying benign and malignant LNs. Subgroup analyses were also conducted to identify potential sources of heterogeneity.</p><p><strong>Results: </strong>A total of 1,355 studies were identified and reviewed. Among these studies, 19 studies met the inclusion criteria, and 2,354 cases were included in the analysis. The pooled sensitivity, specificity, and DOR of ultrasound-based machine learning in classifying benign and malignant LNs were 0.836 (95% CI [0.805, 0.863]), 0.850 (95% CI [0.805, 0.886]), and 33.331 (95% CI [22.873, 48.57]), respectively, indicating no publication bias (p = 0.12). Subgroup analyses may suggest that the location of lymph nodes, validation methods, and type of primary tumor are the sources of heterogeneity.</p><p><strong>Conclusion: </strong>AI can accurately differentiate benign from malignant LNs. Given the widespread use of ultrasonography in diagnosing malignant LNs in cancer patients, there is significant potential for integrating AI-based decision support systems into clinical practice to enhance the diagnostic accuracy.</p>","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":"25 1","pages":"73"},"PeriodicalIF":3.4000,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11726910/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12885-025-13447-y","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objectives: Accurate classification of lymphadenopathy is essential for determining the pathological nature of lymph nodes (LNs), which plays a crucial role in treatment selection. The biopsy method is invasive and carries the risk of sampling failure, while the utilization of non-invasive approaches such as ultrasound can minimize the probability of iatrogenic injury and infection. With the advancement of artificial intelligence (AI) and machine learning, the diagnostic efficiency of LNs is further enhanced. This study evaluates the performance of ultrasound-based AI applications in the classification of benign and malignant LNs.

Methods: The literature research was conducted using the PubMed, EMBASE, and Cochrane Library databases as of June 2024. The quality of the included studies was evaluated using the QUADAS-2 tool. The pooled sensitivity, specificity, and diagnostic odds ratio (DOR) were calculated to assess the diagnostic efficacy of ultrasound-based AI in classifying benign and malignant LNs. Subgroup analyses were also conducted to identify potential sources of heterogeneity.

Results: A total of 1,355 studies were identified and reviewed. Among these studies, 19 studies met the inclusion criteria, and 2,354 cases were included in the analysis. The pooled sensitivity, specificity, and DOR of ultrasound-based machine learning in classifying benign and malignant LNs were 0.836 (95% CI [0.805, 0.863]), 0.850 (95% CI [0.805, 0.886]), and 33.331 (95% CI [22.873, 48.57]), respectively, indicating no publication bias (p = 0.12). Subgroup analyses may suggest that the location of lymph nodes, validation methods, and type of primary tumor are the sources of heterogeneity.

Conclusion: AI can accurately differentiate benign from malignant LNs. Given the widespread use of ultrasonography in diagnosing malignant LNs in cancer patients, there is significant potential for integrating AI-based decision support systems into clinical practice to enhance the diagnostic accuracy.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
人工智能在超声淋巴结诊断中的表现:系统回顾和荟萃分析。
背景与目的:淋巴结病的准确分类对于确定淋巴结的病理性质至关重要,在治疗选择中起着至关重要的作用。活检方法是侵入性的,有取样失败的风险,而采用超声等非侵入性方法可以最大限度地减少医源性损伤和感染的可能性。随着人工智能(AI)和机器学习的发展,LNs的诊断效率进一步提高。本研究评估了基于超声的AI应用在良恶性LNs分类中的表现。方法:采用截至2024年6月的PubMed、EMBASE和Cochrane Library数据库进行文献研究。使用QUADAS-2工具评估纳入研究的质量。计算合并的敏感性、特异性和诊断优势比(DOR),评估基于超声的AI对良恶性LNs的诊断效果。还进行了亚组分析,以确定潜在的异质性来源。结果:共有1355项研究被确定和审查。其中19项研究符合纳入标准,2354例纳入分析。基于超声的机器学习分类良恶性LNs的总敏感性、特异性和DOR分别为0.836 (95% CI[0.805, 0.863])、0.850 (95% CI[0.805, 0.886])和33.331 (95% CI[22.873, 48.57]),无发表偏倚(p = 0.12)。亚组分析可能表明,淋巴结的位置、验证方法和原发肿瘤的类型是异质性的来源。结论:人工智能可准确区分良恶性LNs。鉴于超声在癌症患者恶性LNs诊断中的广泛应用,将基于人工智能的决策支持系统整合到临床实践中以提高诊断准确性具有重大潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMC Cancer
BMC Cancer 医学-肿瘤学
CiteScore
6.00
自引率
2.60%
发文量
1204
审稿时长
6.8 months
期刊介绍: BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.
期刊最新文献
Development and validation of a prognostic prediction model for elderly gastric cancer patients based on oxidative stress biochemical markers. Efficacy and safety of reduced-port laparoscopic surgery versus conventional laparoscopic surgery for colorectal cancer. Incidence and risk of endocrine and metabolic abnormalities linked to PARP inhibitors in solid tumors: a meta-analysis. Intravoxel incoherent motion (IVIM) MRI-derived masseter muscle characteristics: a new diagnostic marker in head and neck cancer? The global, regional burden of pancreatic cancer and its attributable risk factors from 1990 to 2021.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1